Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode one of four, Dr. Jeff Carstens discusses with Drs. Tom Draper and Michael Montgomery steps to developing a ...

There is a significant and independent prognostic value of ESC criteria for suspected myocarditis and the updated Lake-Louise criteria (LLC), respectively. ESC criteria were positive in a larger ...

This nationwide cohort study reports decreased risks of several serious CV outcomes after COVID-19 vaccination, likely related to the protection of vaccination against severe COVID-19. However, ...

Patients with chronic kidney disease (CKD) whose systolic blood pressure (SBP), LDL-C and fasting blood glucose (FBG) were controlled to target levels experienced a similar number of primary outcome ...

Exercise therapy should be started in the early phases of treatment and continued thereafter to diminish declines in cardiorespiratory fitness from cancer therapy. Liposomal anthracycline or ...

The outcome of the 2024 election will have a significant effect on the future of health policy in the U.S., according to a special report published in the New England Journal of Medicine on Oct. 2.

The current retrospective analysis from national Danish registries looked to assess the risk of recurrent stroke among patients who underwent PFO closure for cryptogenic stroke and compared these ...

Rick Steward, MD, MBA, FACC ACC Caribbean Consortium Chapter Governor Daniel Quesada, MD, FACC ACC Central American Consortium Chapter Governor ...

ACC Legislative Conference 2024, taking place Sept. 29-Oct. 1 in Washington, DC, offers cardiovascular clinicians spanning the entire cardiovascular care team a chance to hear from ACC leaders, staff ...